213 related articles for article (PubMed ID: 2536096)
1. The Epstein-Barr virus (EBV) early promoter DR contains a cis-acting element responsive to the EBV transactivator EB1 and an enhancer with constitutive and inducible activities.
Chavrier P; Gruffat H; Chevallier-Greco A; Buisson M; Sergeant A
J Virol; 1989 Feb; 63(2):607-14. PubMed ID: 2536096
[TBL] [Abstract][Full Text] [Related]
2. The Epstein-Barr virus (EBV) DR enhancer contains two functionally different domains: domain A is constitutive and cell specific, domain B is transactivated by the EBV early protein R.
Chevallier-Greco A; Gruffat H; Manet E; Calender A; Sergeant A
J Virol; 1989 Feb; 63(2):615-23. PubMed ID: 2536097
[TBL] [Abstract][Full Text] [Related]
3. The Epstein-Barr virus (EBV) ORI1yt enhancer is not B-cell specific and does not respond synergistically to the EBV transcription factors R and Z.
Gruffat H; Moreno N; Sergeant A
J Virol; 1990 Jun; 64(6):2810-8. PubMed ID: 2159545
[TBL] [Abstract][Full Text] [Related]
4. The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators.
Kenney S; Holley-Guthrie E; Mar EC; Smith M
J Virol; 1989 Sep; 63(9):3878-83. PubMed ID: 2548003
[TBL] [Abstract][Full Text] [Related]
5. The Epstein-Barr virus early protein EB1 activates transcription from different responsive elements including AP-1 binding sites.
Urier G; Buisson M; Chambard P; Sergeant A
EMBO J; 1989 May; 8(5):1447-53. PubMed ID: 2548844
[TBL] [Abstract][Full Text] [Related]
6. trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.
Reisman D; Sugden B
Mol Cell Biol; 1986 Nov; 6(11):3838-46. PubMed ID: 3025615
[TBL] [Abstract][Full Text] [Related]
7. A CACCC box-like cis-regulatory element of the Epstein-Barr virus ED-L2 promoter interacts with a novel transcriptional factor in tissue-specific squamous epithelia.
Nakagawa H; Inomoto T; Rustgi AK
J Biol Chem; 1997 Jun; 272(26):16688-99. PubMed ID: 9195985
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.
Le Roux F; Sergeant A; Corbo L
J Gen Virol; 1996 Mar; 77 ( Pt 3)():501-9. PubMed ID: 8601788
[TBL] [Abstract][Full Text] [Related]
9. EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus.
Sung NS; Kenney S; Gutsch D; Pagano JS
J Virol; 1991 May; 65(5):2164-9. PubMed ID: 1850003
[TBL] [Abstract][Full Text] [Related]
10. Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression.
Tsang SF; Wang F; Izumi KM; Kieff E
J Virol; 1991 Dec; 65(12):6765-71. PubMed ID: 1658373
[TBL] [Abstract][Full Text] [Related]
11. A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen.
Hardwick JM; Lieberman PM; Hayward SD
J Virol; 1988 Jul; 62(7):2274-84. PubMed ID: 2836611
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
[TBL] [Abstract][Full Text] [Related]
13. Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter.
Chevallier-Greco A; Manet E; Chavrier P; Mosnier C; Daillie J; Sergeant A
EMBO J; 1986 Dec; 5(12):3243-9. PubMed ID: 3028777
[TBL] [Abstract][Full Text] [Related]
14. An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators.
Cox MA; Leahy J; Hardwick JM
J Virol; 1990 Jan; 64(1):313-21. PubMed ID: 2152819
[TBL] [Abstract][Full Text] [Related]
15. The Epstein-Barr virus (EBV) early protein EB2 is a posttranscriptional activator expressed under the control of EBV transcription factors EB1 and R.
Buisson M; Manet E; Trescol-Biemont MC; Gruffat H; Durand B; Sergeant A
J Virol; 1989 Dec; 63(12):5276-84. PubMed ID: 2555554
[TBL] [Abstract][Full Text] [Related]
16. The 5' flanking region of the gene for the Epstein-Barr virus-encoded nuclear antigen 2 contains a cell type specific cis-acting regulatory element that activates transcription in transfected B-cells.
Ricksten A; Olsson A; Andersson T; Rymo L
Nucleic Acids Res; 1988 Sep; 16(17):8391-410. PubMed ID: 2843816
[TBL] [Abstract][Full Text] [Related]
17. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
Nilsson T; Sjöblom A; Masucci MG; Rymo L
Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
[TBL] [Abstract][Full Text] [Related]
18. The zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus-infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions.
Lieberman PM; Hardwick JM; Sample J; Hayward GS; Hayward SD
J Virol; 1990 Mar; 64(3):1143-55. PubMed ID: 2154599
[TBL] [Abstract][Full Text] [Related]
19. The lytic origin of herpesvirus papio is highly homologous to Epstein-Barr virus ori-Lyt: evolutionary conservation of transcriptional activation and replication signals.
Ryon JJ; Fixman ED; Houchens C; Zong J; Lieberman PM; Chang YN; Hayward GS; Hayward SD
J Virol; 1993 Jul; 67(7):4006-16. PubMed ID: 8389916
[TBL] [Abstract][Full Text] [Related]
20. Novel 12-O-tetradecanoylphorbol-13-acetate-responsive elements in the upstream sequence of the MS gene promoter of Epstein-Barr virus.
Liu QY; Summers WC
J Virol; 1989 Dec; 63(12):5062-8. PubMed ID: 2555542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
